bioAffinity Technologies, Inc. Announces Webinar on Veteran Lung Health Screening

bioAffinity Technologies, Inc. announced a webinar scheduled for July 21, 2026, focusing on emerging approaches to lung health screening and early detection for veterans at increased risk for lung cancer and other respiratory diseases. The webinar will feature clinical experts discussing current challenges, advances in diagnostic technologies, and strategies to improve outcomes for veterans, particularly those potentially impacted by toxic exposures. The event will explore topics such as lung cancer risk in veterans, the role of imaging, noninvasive diagnostic approaches, and improving access to care. Speakers include Rashi Romanoff from NAVREF, Amy Rohs from Philips, Michael Nicholson discussing CyPath® Lung, and Greg Mogel from 4DMedical. The webinar aims to provide healthcare professionals with insights into supporting improved outcomes for at-risk patients. CyPath® Lung, bioAffinity Technologies' noninvasive test for early lung cancer detection, will also be highlighted.